Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | KIAA1468 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |
mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |